Abstract 3185: SCR-A019, a first-in-class biparatopic ADC targeting MSLN, with a novel topoisomerase I inhibitor demonstrates encouraging efficacy in preclinical models
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Qiong Wang, Yayuan Fu, Qi Deng, Chunlei Xia, Hui Zheng, Youfu Chu, Renhong Tang
Institution: Simcere Pharmaceutical (China)
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148892775
Cites:
Cited by:
Related to: